Latest News
Investor Relations
Latest News
February 26, 2024 10:39 am
PRISM MarketView Spotlights BioStem Technologies in the Expanding Wound Care Market
January 30, 2024 04:05 pm
Amniowrap2(TM) Product Launch Leads Year of Highlights for BioStem Technologies
January 11, 2024 08:30 am
BioStem Technologies Appoints Proven Life Science Sales Leader Shawn McCarrey to Chief Commercial Officer Role
December 19, 2023 08:30 am
BioStem Technologies Appoints Executive Leader Patrick Daly to Board of Directors
December 14, 2023 08:30 am
Center for Medicare Services Established National Pricing of AmnioWrap2(TM) in All MAC Regions
December 13, 2023 08:30 am
BioStem Technologies Bolsters Leadership with Appointment of Thomas Dugan to Board of Directors
November 13, 2023 05:17 pm
BioStem Technologies Reports Third Quarter 2023 Operating and Financial Results
November 8, 2023 08:30 am
BioStem Technologies Awarded Q Code for VENDAJE AC® Line from Centers for Medicare and Medicaid Services
November 6, 2023 08:30 am
BioStem Technologies to Report Third Quarter 2023 Financial Results on Tuesday, November 14, 2023
November 3, 2023 08:30 am